nsc 615985 and delavirdine

nsc 615985 has been researched along with delavirdine in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kang, X; Kollman, PA; Kuntz, ID; Wang, J	1
Balzarini, J; Camarasa, MJ; De Clercq, E; Karlsson, A; Pérez-Pérez, MJ; San-Félix, A; Vélazquez, S	1

Other Studies

2 other study(ies) available for nsc 615985 and delavirdine

Article	Year
Hierarchical database screenings for HIV-1 reverse transcriptase using a pharmacophore model, rigid docking, solvation docking, and MM-PB/SA. Journal of medicinal chemistry, 2005, Apr-07, Volume: 48, Issue:7 Topics: Allosteric Site; Anti-HIV Agents; Crystallography, X-Ray; Databases, Factual; Drug Design; HIV Reverse Transcriptase; Models, Molecular; Molecular Conformation; Molecular Structure; Protein Binding; Quantitative Structure-Activity Relationship; Reverse Transcriptase Inhibitors; Statistics as Topic; Thermodynamics	2005
Suppression of the breakthrough of human immunodeficiency virus type 1 (HIV-1) in cell culture by thiocarboxanilide derivatives when used individually or in combination with other HIV-1-specific inhibitors (i.e., TSAO derivatives). Proceedings of the National Academy of Sciences of the United States of America, 1995, Jun-06, Volume: 92, Issue:12 Topics: Antiviral Agents; Base Sequence; Carboxin; Cell Line; Delavirdine; DNA Primers; Drug Antagonism; HIV Reverse Transcriptase; HIV-1; Humans; Indoles; Molecular Sequence Data; Mutation; Piperazines; Reverse Transcriptase Inhibitors; Spiro Compounds; Thymidine	1995

Article

Year

Hierarchical database screenings for HIV-1 reverse transcriptase using a pharmacophore model, rigid docking, solvation docking, and MM-PB/SA.

Journal of medicinal chemistry, 2005, Apr-07, Volume: 48, Issue:7

Topics: Allosteric Site; Anti-HIV Agents; Crystallography, X-Ray; Databases, Factual; Drug Design; HIV Reverse Transcriptase; Models, Molecular; Molecular Conformation; Molecular Structure; Protein Binding; Quantitative Structure-Activity Relationship; Reverse Transcriptase Inhibitors; Statistics as Topic; Thermodynamics

2005

Suppression of the breakthrough of human immunodeficiency virus type 1 (HIV-1) in cell culture by thiocarboxanilide derivatives when used individually or in combination with other HIV-1-specific inhibitors (i.e., TSAO derivatives).

Proceedings of the National Academy of Sciences of the United States of America, 1995, Jun-06, Volume: 92, Issue:12

Topics: Antiviral Agents; Base Sequence; Carboxin; Cell Line; Delavirdine; DNA Primers; Drug Antagonism; HIV Reverse Transcriptase; HIV-1; Humans; Indoles; Molecular Sequence Data; Mutation; Piperazines; Reverse Transcriptase Inhibitors; Spiro Compounds; Thymidine

1995